[HTML][HTML] Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
X Huang, J Ma, Y Wei, H Chen, W Chu - Frontiers in Genetics, 2023 - frontiersin.org
Background: Accumulating evidence suggests that postmenopausal osteoporosis (PMOP) is
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
[HTML][HTML] Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
X Huang, J Ma, Y Wei, H Chen, W Chu - Frontiers in Genetics, 2023 - ncbi.nlm.nih.gov
Background: Accumulating evidence suggests that postmenopausal osteoporosis (PMOP) is
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning.
X Huang, J Ma, Y Wei, H Chen, W Chu - Frontiers in Genetics, 2023 - europepmc.org
Background: Accumulating evidence suggests that postmenopausal osteoporosis (PMOP) is
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
X Huang, J Ma, Y Wei, H Chen… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background: Accumulating evidence suggests that postmenopausal osteoporosis (PMOP) is
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …
a common chronic systemic metabolic bone disease, but its specific molecular pathogenesis …